To our knowledge, no markers yet exist that are specific for only brain tumour cells of the IDH-wildtype (off note: accurate stainings for IDH1 R132H mutant tumour cells do exist); showing the need to develop better high-grade glioma cell-markers. The gene discussed is IDH1; the disease is central nervous system cancer.